Chapter
Challenges Faced by Regulators and Pharmaceutical Companies During Vaccine Development
11:19 - 16:03 (04:43)
The podcast discusses the challenges faced by regulators and pharmaceutical companies during the development of COVID-19 vaccines, including the pressure to quickly develop a vaccine amidst uncertainty and fear of the pandemic, and the potential influence of the costs invested in vaccine development on conducting unbiased studies.
Clips
This episode discusses the development and investment behind the Pfizer-BioNTech COVID-19 vaccine, including the high risks and cost of research and development.
11:19 - 12:46 (01:27)
Summary
This episode discusses the development and investment behind the Pfizer-BioNTech COVID-19 vaccine, including the high risks and cost of research and development.
ChapterChallenges Faced by Regulators and Pharmaceutical Companies During Vaccine Development
Episode#249 – Albert Bourla: Pfizer CEO
PodcastLex Fridman Podcast
In the rush to develop vaccines during the pandemic, there is a pressure to cover the costs that were invested in it, which could harm the ability to conduct unbiased studies.
12:46 - 16:03 (03:16)
Summary
In the rush to develop vaccines during the pandemic, there is a pressure to cover the costs that were invested in it, which could harm the ability to conduct unbiased studies. However, the focus should be on finding a solution to help the world and bring hope to people.